Prolonged analgesia by enkephalinase inhibition in rats with spinal cord adrenal medullary transplants

Jacqueline Sagen, Hong Wang

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Transplants of adrenal medullary tissue or isolated chromaffin cells into the spinal cord subarachnoid space has been shown to reduce pain sensitivity in rats. This analgesia probably results from the release of neuroactive substances, particularly opioid peptides, from the transplanted cells since it is induced by nicotinic stimulation of chromaffin cell receptors, and can be blocked by naloxone. However, this analgesia is short-lived, most likely due to the rapid hydrolysis of opioid peptides. The purpose of this study was to determine whether protection of opioid peptide hydrolysis by the potent enkephalinase inhibitor kelatorphan could prolong this analgesia. Results indicated that the intrathecal injection of kelatorphan in animals with either adrenal medullary or chromaffin cell implants significantly prolonged nicotine-stimulated analgesia. Pretreatment with naloxone completely eliminated this analgesia. These results suggest that it may be possible to induce long-term reductions in pain sensitivity using enkephalinase inhibitors following the transplantation of opioid peptide-producing cells into the CNS.

Original languageEnglish
Pages (from-to)427-433
Number of pages7
JournalEuropean Journal of Pharmacology
Volume179
Issue number3
DOIs
StatePublished - Apr 25 1990
Externally publishedYes

Fingerprint

Neprilysin
Opioid Peptides
Analgesia
Spinal Cord
Chromaffin Cells
Transplants
Naloxone
Hydrolysis
Pain
Spinal Injections
Subarachnoid Space
Nicotine
Transplantation
Inhibition (Psychology)

Keywords

  • Chromaffin cells
  • Enkephalinase
  • Neural grafts
  • Nociception
  • Pain modulation

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Prolonged analgesia by enkephalinase inhibition in rats with spinal cord adrenal medullary transplants. / Sagen, Jacqueline; Wang, Hong.

In: European Journal of Pharmacology, Vol. 179, No. 3, 25.04.1990, p. 427-433.

Research output: Contribution to journalArticle

@article{5443da6ef8684ecfbefe61f771e9c699,
title = "Prolonged analgesia by enkephalinase inhibition in rats with spinal cord adrenal medullary transplants",
abstract = "Transplants of adrenal medullary tissue or isolated chromaffin cells into the spinal cord subarachnoid space has been shown to reduce pain sensitivity in rats. This analgesia probably results from the release of neuroactive substances, particularly opioid peptides, from the transplanted cells since it is induced by nicotinic stimulation of chromaffin cell receptors, and can be blocked by naloxone. However, this analgesia is short-lived, most likely due to the rapid hydrolysis of opioid peptides. The purpose of this study was to determine whether protection of opioid peptide hydrolysis by the potent enkephalinase inhibitor kelatorphan could prolong this analgesia. Results indicated that the intrathecal injection of kelatorphan in animals with either adrenal medullary or chromaffin cell implants significantly prolonged nicotine-stimulated analgesia. Pretreatment with naloxone completely eliminated this analgesia. These results suggest that it may be possible to induce long-term reductions in pain sensitivity using enkephalinase inhibitors following the transplantation of opioid peptide-producing cells into the CNS.",
keywords = "Chromaffin cells, Enkephalinase, Neural grafts, Nociception, Pain modulation",
author = "Jacqueline Sagen and Hong Wang",
year = "1990",
month = "4",
day = "25",
doi = "10.1016/0014-2999(90)90184-8",
language = "English",
volume = "179",
pages = "427--433",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Prolonged analgesia by enkephalinase inhibition in rats with spinal cord adrenal medullary transplants

AU - Sagen, Jacqueline

AU - Wang, Hong

PY - 1990/4/25

Y1 - 1990/4/25

N2 - Transplants of adrenal medullary tissue or isolated chromaffin cells into the spinal cord subarachnoid space has been shown to reduce pain sensitivity in rats. This analgesia probably results from the release of neuroactive substances, particularly opioid peptides, from the transplanted cells since it is induced by nicotinic stimulation of chromaffin cell receptors, and can be blocked by naloxone. However, this analgesia is short-lived, most likely due to the rapid hydrolysis of opioid peptides. The purpose of this study was to determine whether protection of opioid peptide hydrolysis by the potent enkephalinase inhibitor kelatorphan could prolong this analgesia. Results indicated that the intrathecal injection of kelatorphan in animals with either adrenal medullary or chromaffin cell implants significantly prolonged nicotine-stimulated analgesia. Pretreatment with naloxone completely eliminated this analgesia. These results suggest that it may be possible to induce long-term reductions in pain sensitivity using enkephalinase inhibitors following the transplantation of opioid peptide-producing cells into the CNS.

AB - Transplants of adrenal medullary tissue or isolated chromaffin cells into the spinal cord subarachnoid space has been shown to reduce pain sensitivity in rats. This analgesia probably results from the release of neuroactive substances, particularly opioid peptides, from the transplanted cells since it is induced by nicotinic stimulation of chromaffin cell receptors, and can be blocked by naloxone. However, this analgesia is short-lived, most likely due to the rapid hydrolysis of opioid peptides. The purpose of this study was to determine whether protection of opioid peptide hydrolysis by the potent enkephalinase inhibitor kelatorphan could prolong this analgesia. Results indicated that the intrathecal injection of kelatorphan in animals with either adrenal medullary or chromaffin cell implants significantly prolonged nicotine-stimulated analgesia. Pretreatment with naloxone completely eliminated this analgesia. These results suggest that it may be possible to induce long-term reductions in pain sensitivity using enkephalinase inhibitors following the transplantation of opioid peptide-producing cells into the CNS.

KW - Chromaffin cells

KW - Enkephalinase

KW - Neural grafts

KW - Nociception

KW - Pain modulation

UR - http://www.scopus.com/inward/record.url?scp=0025254358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025254358&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(90)90184-8

DO - 10.1016/0014-2999(90)90184-8

M3 - Article

C2 - 2364994

AN - SCOPUS:0025254358

VL - 179

SP - 427

EP - 433

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 3

ER -